Andrews Julie 4
4 · RxSight, Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Andrews Julie
Director
Transactions
- Sale
Common Stock
2024-06-14$58.53/sh−3,685$215,680→ 30,287 total - Sale
Common Stock
2024-06-14$57.84/sh−11,940$690,608→ 33,972 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2024 by the Reporting Person.
- [F2]Represents the weighted average share price of an aggregate total of 11,940 shares sold in the price range of $57.32 to $58.29 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 3,685 shares sold in the price range of $58.32 to $59.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.